These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 2944928)
1. The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants. Davidson J; Pelton S; Krishnan RR; Allf B J Affect Disord; 1986; 11(1):51-8. PubMed ID: 2944928 [TBL] [Abstract][Full Text] [Related]
2. Forms of atypical depression and their response to antidepressant drugs. Davidson J; Pelton S Psychiatry Res; 1986 Feb; 17(2):87-95. PubMed ID: 3083445 [TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy. Tiller JW; Mitchell P; Burrows GD Aust N Z J Psychiatry; 1992 Jun; 26(2):327-9. PubMed ID: 1642632 [No Abstract] [Full Text] [Related]
4. [Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression]. Rosan TA; Mesones HL; Brengio F Acta Psiquiatr Psicol Am Lat; 1994 Dec; 40(4):314-20. PubMed ID: 7484185 [TBL] [Abstract][Full Text] [Related]
5. The drug treatment of anxiety and depression. Cole JO Med Clin North Am; 1988 Jul; 72(4):815-30. PubMed ID: 3287039 [TBL] [Abstract][Full Text] [Related]
6. Differential response patterns to MAO inhibitors and tricyclics. Nies A J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [TBL] [Abstract][Full Text] [Related]
11. Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression. Kim T; Xu C; Amsterdam JD J Affect Disord; 2019 May; 250():199-203. PubMed ID: 30861462 [TBL] [Abstract][Full Text] [Related]
12. Cerebral laterality and depression: relations of perceptual asymmetry to outcome of treatment with tricyclic antidepressants. Bruder GE; Stewart JW; Voglmaier MM; Harrison WM; McGrath P; Tricamo E; Quitkin FM Neuropsychopharmacology; 1990 Feb; 3(1):1-10. PubMed ID: 2306330 [TBL] [Abstract][Full Text] [Related]
13. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia. Pohl R; Berchou R; Rainey JM J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863 [TBL] [Abstract][Full Text] [Related]
14. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression. Feighner JP; Herbstein J; Damlouji N J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. Goodman WK; Charney DS J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056 [TBL] [Abstract][Full Text] [Related]
16. Panic attacks. A review of treatments and pathogenesis. Grunhaus L; Gloger S; Weisstub E J Nerv Ment Dis; 1981 Oct; 169(10):608-13. PubMed ID: 6116741 [TBL] [Abstract][Full Text] [Related]
17. [Combining a classic monoamine oxidase inhibitor with a tricyclic antidepressant in therapy-resistant depression: a case report and literature review]. Schipper P; Vanmolkot L; Peeters FP Tijdschr Psychiatr; 2016; 58(12):886-890. PubMed ID: 27976787 [TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase inhibitors. Lippmann S Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254 [TBL] [Abstract][Full Text] [Related]
19. Influence of personality on response to monoamine oxidase inhibitors and tricyclic antidepressants. Shawcross CR; Tyrer P J Psychiatr Res; 1985; 19(4):557-62. PubMed ID: 4078758 [TBL] [Abstract][Full Text] [Related]